Compare Injective (INJ) vs Sui (SUI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Sui — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,76T 24h volume), while Sui trades at Rp13,650 (market cap Rp55,34T, Rp3,77T 24h volume). The key difference: Sui is far larger — about 6× Injective's market cap, and Sui's supply is capped (4,1B / 10B SUI (41%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Sui for 35 Days on average.
| INJ | SUI | |
|---|---|---|
Market Cap | Rp9,29T | Rp55,34T |
Volume (24h) | Rp1,76T | Rp3,77T |
Circulating Supply | 100M INJ | 4,1B / 10B SUI (41%) |
Typical Hold Time | 36 Days | 35 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Sui is currently trading at Rp13,524 with a market cap of Rp54.78T, showing bullish technical signals across moving averages and oscillators. The token maintains 41% circulation with strong ADX indicators suggesting trending momentum. Recent ecosystem growth includes developer activity and protocol optimizations, though RSI levels indicate potential short-term overbought conditions. Support levels are established at Rp12,434-13,576 while resistance sits at Rp14,122-14,966.
Overall outlook remains cautiously bullish with strong technical momentum but faces overbought risks near-term. Key opportunities include continued ecosystem expansion and developer adoption, while major risks involve regulatory uncertainty and typical crypto volatility. Investors should monitor support levels closely given current RSI readings.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Sui
Sui is a first-of-its-kind Layer-1 blockchain and smart contract platform designed from the bottom up to make digital asset ownership fast, private, secure, and accessible to everyone. Based on the Move programming language, its object-centric model enables parallel execution, sub-second finality, and rich on-chain assets. Sui supports a wide range of applications with unrivaled speed at a low cost.
Read more on SUI →
